MARKETING TOOLS ORDER FORM HOJA PEDIDO ELEMENTOS … · rms-610,rms-613,rms-617,rms-623,rms-628
Bioterror i Rms 2
-
Upload
savya-jaiswal -
Category
Documents
-
view
215 -
download
0
Transcript of Bioterror i Rms 2
-
7/28/2019 Bioterror i Rms 2
1/37
BIOTERRORISMPRESENTERS: 61-70
DATE OF PRESENTATION: 11-2-08
-
7/28/2019 Bioterror i Rms 2
2/37
MEMBERS
61
SHAVETA PURI
62SHEIFALI SINGH
63SHIKHA GANERIWAL
64
SHIKHA RAINA 65SHIVANGI SRIVASTAV
66SHOBHIKA KHURANA
67SHUBHI NIGAM
68
SHWETA SINGH 69SHWETA SINGH
70SHWETA SINGH
-
7/28/2019 Bioterror i Rms 2
3/37
Disease has longbeen the deadliest
enemy of mankind...
President George Bush
-
7/28/2019 Bioterror i Rms 2
4/37
What isBioterrorism?
The deliberate
release off anthrax,smallpox, ebola,
plague, or anyhighly fatalorganism in a largeunsuspectingpopulation
-
7/28/2019 Bioterror i Rms 2
5/37
Many of These Agents
Inhaled
Through skin or eaten
Are not contagious anthrax Are highly contagious smallpox
-
7/28/2019 Bioterror i Rms 2
6/37
History
Assyrians
Plague
Smallpox World War I
World War II
research
-
7/28/2019 Bioterror i Rms 2
7/37
World War II
1940 plague epidemic in China andManchuria
By 1945, Japanese stockpiled anthrax
U.S. began research in 1943
-
7/28/2019 Bioterror i Rms 2
8/37
History
Convention on the Prohibition of theDevelopment, Production, andStockpiling of Bacteriological and
Toxin Weapons
the Biological Weapons Convention(1972)
-
7/28/2019 Bioterror i Rms 2
9/37
History
Yellow Rain in Southeast Asia
Anthrax in Sverdlovsk
Ricin umbrella assassination inLondon
-
7/28/2019 Bioterror i Rms 2
10/37
History
Iraq
-
7/28/2019 Bioterror i Rms 2
11/37
History
Anthrax Mailings
-
7/28/2019 Bioterror i Rms 2
12/37
The Threat
-
7/28/2019 Bioterror i Rms 2
13/37
Attacks by Al-Qaida
U.S. Embassies inKenya and Tanzania
U.S.S. Cole
World Trade Center and
Pentagon Tunis synagogue in
2002
U.S. Consulate General
in Karachi (2002) Suicide bombings at
U.S. Housingcompounds in Riyadh
-
7/28/2019 Bioterror i Rms 2
14/37
Threat remains real
Terrorist groups other than Al-Qaida
Increasing interest in biologicalweapons
-
7/28/2019 Bioterror i Rms 2
15/37
Motivation
Create mass casualties Overwhelm emergency response
systems
Disrupt normal routine Shut down and contaminate facilities Create panic and confusion
Loss off faith in ability to preventattacks
-
7/28/2019 Bioterror i Rms 2
16/37
Terrorists Considerations
Terrorists can easilymaintain covert andclandestine posture
Small quantities createlarge impact
Biological weapons areinexpensive
Agents difficult todetect
Biological weaponspotentially availablefrom states that supportterrorism
-
7/28/2019 Bioterror i Rms 2
17/37
Terrorists Considerations(continued)
Soviet disintegration increasedconcerns about protection, control, andaccountability of agents
Agents need not be pure to createcasualties
Attacks create psychological damageregardless of casualties
-
7/28/2019 Bioterror i Rms 2
18/37
Potential Targets
Tendency toward large, indiscriminate targetswith high contamination rate
Mass transit systemsModern office buildings
Large indoor shopping areasAirports, crowded ports, and train
stationsCongested, open-air events with
restricted exit routesLarge indoor sport arenas, convention
centers, concert hall
-
7/28/2019 Bioterror i Rms 2
19/37
Current Biological
Weapons Programs 10-12 countries pursuing biological
weapons programs Black market
Materials used in universities / medical
research vulnerable
-
7/28/2019 Bioterror i Rms 2
20/37
Facilities
Production requires rudimentary skillsand facilities
Production can be hidden behindscreen of legitimate research
-
7/28/2019 Bioterror i Rms 2
21/37
Mission
Be prepared! Long-term strategy Significant investment iin healthcare
system
-
7/28/2019 Bioterror i Rms 2
22/37
U.S. Response Today
Improvements in preparedness
National stockpile of medical countermeasures expanded and more
accessible Additional diagnostic tests, drugs, and
vaccines under development
-
7/28/2019 Bioterror i Rms 2
23/37
Since 9/11 Steps Taken
HS Office of Public HealthPreparedness to addressbioterrorist threats
New director of CDC isnoted for her work in
combating anthrax andbioterrorism
Plans announced toinoculate 10 million healthcare, emergency, law
enforcement, and militarypersonnel againstsmallpox
System designed to detectairborne release of anthrax
and smallpox
-
7/28/2019 Bioterror i Rms 2
24/37
Since 9/11 (continued)
Increase in funding to combat terrorism
June 2002 bioterrorism law for stockpilingmedicines and vaccines
Project Bioshield proposes spending $5.9billion to defend against bioterrorism
NIH development capabilities strengthened
Make promising treatments quickly available
-
7/28/2019 Bioterror i Rms 2
25/37
Diseases of Concern
High death rates
Public panic
Require special attention to cure andcontain
-
7/28/2019 Bioterror i Rms 2
26/37
Anthrax
Danger depends on various factors
Not contagious
Three methods of contamination- Skin anthrax: 5 to 20% fatality
- Lung anthrax: 80% fatality
- Ingested anthrax: 70% fatality
-
7/28/2019 Bioterror i Rms 2
27/37
Smallpox
Extremely contagious virus
30% fatality rate
No known cure Vaccine prevents infection and reduces
severity of illness
-
7/28/2019 Bioterror i Rms 2
28/37
Botulism
Potentially fatal, but noncontiguous
-
7/28/2019 Bioterror i Rms 2
29/37
Plagues
Bubonic Plague
- Carried by rodents, transmitted byfleabites
- Cannot spread from person to person
- More common, less deadly
-
7/28/2019 Bioterror i Rms 2
30/37
Pneumonic Plague
Affects lungs
Travels through air, highly contagious
Very rare and lethal 100% mortality, if untreated
-
7/28/2019 Bioterror i Rms 2
31/37
Tularemia
Carried by small mammals
As a weapon aerolsolized
Death rates could climb to 60%
-
7/28/2019 Bioterror i Rms 2
32/37
Hemorrhagic Fever
Deadly class of viruses
HVFs carried by animals in Africa, Asia,Middle East, and South America
Cause of spread unknown
Transmitted via blood or other bodily
-
7/28/2019 Bioterror i Rms 2
33/37
Responding Agencies
Department of Homeland Security- Federal Emergency Management Agency
Department of Health and Human Resources
- Centers for Disease Control
Monitors public health threats
- National Institutes of Health
Oversees infectious disease researchand new drug therapies
Department of Defense
- Research and detection of biowarfare agents
First line of response clinicians and hospital
personnel
-
7/28/2019 Bioterror i Rms 2
34/37
If there is an attack ...
May not be immediately obvious
Pattern of unusual illness
Become aware through mediabroadcasts
Immediate information on what to domay not be available
-
7/28/2019 Bioterror i Rms 2
35/37
Stay Tuned to Media/Internet
Are you in immediate danger area?
What are signs?
Are medications available?Where?
Who should get them?
Where to seek emergency care?
-
7/28/2019 Bioterror i Rms 2
36/37
REFERENCES
-
7/28/2019 Bioterror i Rms 2
37/37
THANK YOU